Yangxinshi tablets for heart disease with reduced heart function
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether Yangxinshi tablets can help people with coronary heart disease and some degree of heart failure. It looks at improving heart function and safety over the treatment period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with coronary heart disease and are currently hospitalized.
- You are between 40 and 80 years old.
- Your heart function is impaired (NYHA class II to IV), meaning you may feel short of breath or tired with normal activity.
- Your NT-proBNP level is above 125 pg/mL (or BNP above 35 pg/mL), a blood test that shows heart strain.
- A diagnosis of chest obstruction with qi deficiency and blood stasis according to traditional Chinese medicine.
- You are willing to take the study medication and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This trial tests a traditional Chinese herbal formula, Yiyang Huoluo Decoction, for people who still have chest discomfort after getting a stent for coronary heart disease. It aims to see if the herbal treatment can improve symptoms.
This study tests if Yangxinshi tablets can help people with chronic coronary syndrome (a type of heart disease) walk farther or exercise longer. It's for those whose heart condition limits their daily activity.
This trial tests whether a Chinese herbal tablet called Jia Shen can improve heart function and reduce symptoms in people with chronic heart failure caused by coronary heart disease. It aims to find a new option that may help you feel better and stay out of the hospital.
This trial tests SHengXIaN-QuYu decoction (an herbal treatment) in people with symptomatic heart failure and reduced pumping function. It looks to see whether the herbal formula is safe and helpful for heart failure symptoms and heart function.
This trial tests whether Qishen Yiqi Dripping Pills, a Chinese herbal medicine, can help people with chronic heart failure caused by coronary heart disease. It is for adults who have been on stable heart failure treatment for at least two weeks.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.